# Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer

**Authors:** Bi-Cheng Wang

PMC · DOI: 10.1136/jitc-2025-012312 · 2025-04-30

## Full-text entities

- **Genes:** PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}
- **Diseases:** triple-negative breast cancer (MESH:D064726)

---
Source: https://tomesphere.com/paper/PMC12049894